Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Denmark
100%
National Cohort Study
100%
Osteonecrosis of the Jaw
100%
Patients with Cancer
100%
Patient Survival
100%
Cancer Patients
41%
Confidence Interval
25%
Cancer Diagnosis
16%
Mortality Rate
16%
Comparison Cohort
16%
Bone-targeting Agents
16%
Nationwide Registry
8%
Adverse Effects
8%
Comorbidity
8%
Bisphosphonates
8%
Overall Survival
8%
Advanced Disease
8%
Cancer Stage
8%
Distant Metastasis
8%
Cancer Site
8%
Reduced Survival
8%
Lifestyle Characteristics
8%
Nationwide Database
8%
Emigration
8%
1-year Survival
8%
Stage at Diagnosis
8%
Denosumab
8%
3-year Survival
8%
History of Hospitals
8%
Bone Malignancy
8%
Distant Other
8%
Bone-targeted Therapy
8%
Symptomatic Skeletal Events
8%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Cohort Study
100%
Jaw Osteonecrosis
100%
Mortality Rate
16%
Disease
8%
Adverse Event
8%
Comorbidity
8%
Bisphosphonic Acid Derivative
8%
Overall Survival
8%
Distant Metastasis
8%
Denosumab
8%
Biochemistry, Genetics and Molecular Biology
Cohort Study
100%
Mortality Rate
100%
Comorbidity
50%
Overall Survival
50%
Denosumab
50%
Medicine and Dentistry
Cohort Analysis
100%
Osteonecrosis of the Jaw
100%
Malignant Neoplasm
25%
Mortality Rate
16%
Cancer Diagnosis
16%
Disease
8%
Adverse Event
8%
Cancer
8%
Cancer Staging
8%
Bisphosphonate
8%
Overall Survival
8%
Targeted Therapy
8%
Distant Metastasis
8%
Cancer Localization
8%
Denosumab
8%